ASXBlog

The case for ethical investing

David Macri, Australian Ethical

Harnessing the power of money to deliver competitive returns - and positive change for society and the environment

Shareholder activism and dividends

Will Baylis, Legg Mason Martin Currie Equity Income Fund

Active engagement on company dividend payouts improving income returns

How fund managers identify sustainable companies

Matt Patsky, Trillium Asset Management

Effecting positive change in corporate behaviour is part of their process

Using ETFs for ESG investing

Meaghan Victor, State Street Global Advisors

Three powerful trends driving shift to index funds for responsible investing

Behind the boom in responsible investing

Simon O'Connor, RIAA

Allocating capital in companies that improve society

Constructing a sustainable, investable benchmark for Australia

Reid Steadman, S&P Dow Jones Indices

Incorporating environmental, social, and governance data into investments

Resources and Tech lead charge for ASX IPOs 

Josh Collard, ASX

Secondary capital raisings have started to make way for IPOs as companies are dusting off deferred IPO plans to take advantage of current market conditions

Get to know ASX’s new public company: Aroa Biosurgery

Blair Harrison, ASX

Aroa Biosurgery (ASX: ARX) is ASX’s 57th New Zealand IPO and listed with a market capitalisation of $225 million

The Times They Are A Changin’: ASX Emerging as a Force for Tech and its Stakeholders

Richard Horton, Squire Patton Boggs

ASX as a truly robust fundraising and exit platform for mid-stage technology startups both locally and globally represents a remarkable achievement for the ASX in the world of tech

The changing face of capital markets 

James Lee, Jarden

Investors are facing a very simple problem; increased capital for a home in what is now a significantly more volatile and complex market.